NASDAQ:ESTA Establishment Labs (ESTA) Stock Price, News & Analysis $40.69 -0.30 (-0.73%) (As of 11:50 AM ET) Add Compare Share Share Today's Range$40.06▼$41.1250-Day Range$34.40▼$48.9952-Week Range$16.96▼$60.12Volume28,213 shsAverage Volume353,067 shsMarket Capitalization$1.12 billionP/E RatioN/ADividend YieldN/APrice Target$56.60 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Get Establishment Labs alerts: Email Address Establishment Labs MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.80 Rating ScoreUpside/Downside39.1% Upside$56.60 Price TargetShort InterestBearish20.18% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment1.46Based on 4 Articles This WeekInsider TradingSelling Shares$647,806 Sold Last QuarterProj. Earnings GrowthGrowingFrom ($2.12) to ($1.08) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.29 out of 5 starsMedical Sector589th out of 911 stocksSurgical Appliances & Supplies Industry14th out of 17 stocks 3.4 Analyst's Opinion Consensus RatingEstablishment Labs has received a consensus rating of Moderate Buy. The company's average rating score is 2.80, and is based on 4 buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageEstablishment Labs has only been the subject of 3 research reports in the past 90 days.Read more about Establishment Labs' stock forecast and price target. Previous Next 1.0 Short Interest Percentage of Shares Shorted20.18% of the float of Establishment Labs has been sold short.Short Interest Ratio / Days to CoverEstablishment Labs has a short interest ratio ("days to cover") of 15, which indicates bearish sentiment.Change versus previous monthShort interest in Establishment Labs has recently decreased by 3.16%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldEstablishment Labs does not currently pay a dividend.Dividend GrowthEstablishment Labs does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for ESTA. Previous Next 3.0 News and Social Media Coverage News SentimentEstablishment Labs has a news sentiment score of 1.46. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.76 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Establishment Labs this week, compared to 3 articles on an average week. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Establishment Labs insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $647,806.00 in company stock.Percentage Held by Insiders11.44% of the stock of Establishment Labs is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions72.91% of the stock of Establishment Labs is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Establishment Labs' insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Establishment Labs are expected to grow in the coming year, from ($2.12) to ($1.08) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Establishment Labs is -12.96, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Establishment Labs is -12.96, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioEstablishment Labs has a P/B Ratio of 57.31. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Establishment Labs' valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Porter & CompanyTrump’s weapon lurks in abandoned AmericaWhoever wins the presidential election – Trump or Harris – this energy surprise could see their popularity skyrocket… as a new period of wealth and prosperity sweeps across the nation… emanating from the last place anyone could have predicted. Now, billions of dollars are amassing behind this force, with everyone from Jeff Bezos and Bill Gates to Sam Altman and Warren Buffett pouring their money into this phenomenon.To find out more about this American resurrection, go here now to watch my new documentary About Establishment Labs Stock (NASDAQ:ESTA)Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander. The company sells its products to physicians, hospitals, and clinics through distributors and direct sales force in Europe, the Middle East, Latin America, and Asia. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.Read More ESTA Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ESTA Stock News HeadlinesAugust 26, 2024 | msn.comEstablishment Labs Holdings (ESTA) Rebounded in Q2August 23, 2024 | markets.businessinsider.comEstablishment Labs Holdings: A Cautious Hold Amid FDA Approval Process and High Short InterestSeptember 12, 2024 | Crypto 101 Media (Ad)Trillion Dollar Blockchain Shift Could Trigger THIS CoinIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…August 22, 2024 | benzinga.comDeep Dive Into Establishment Labs Hldgs Stock: Analyst Perspectives (5 Ratings)August 14, 2024 | finanznachrichten.deMediPharm Labs Corp.: MediPharm Labs Reports Second Quarter Results Closing in on Positive Adjusted EBITDA as Gross Profit Continues to ImproveAugust 14, 2024 | yahoo.comLawsuit Challenges Florida Lab-Grown Meat BanAugust 13, 2024 | msn.comLab grown diamond industry facing challenge of overcapacity, importsAugust 13, 2024 | msn.comBoth Trump and Harris want to eliminate taxes on tips. This is how it could affect workersSeptember 12, 2024 | Crypto 101 Media (Ad)Trillion Dollar Blockchain Shift Could Trigger THIS CoinIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…August 9, 2024 | finance.yahoo.comEstablishment Labs Holdings Inc. (NASDAQ:ESTA) Just Reported, And Analysts Assigned A US$59.86 Price TargetAugust 6, 2024 | investorplace.comESTA Stock Earnings: Establishment Labs Hldgs Misses EPS, Beats Revenue for Q2 2024August 6, 2024 | msn.comGovernor DeSantis issues updates on Debby response, announces activation of Small Business Emergency Bridge LoanAugust 6, 2024 | msn.comNevro reports mixed Q2 results; initiates Q3 and updates FY24 outlookAugust 6, 2024 | finance.yahoo.comEstablishment Labs Reports Second Quarter 2024 Financial ResultsAugust 6, 2024 | benzinga.comEstablishment Labs Hldgs Unusual Options Activity For August 06August 6, 2024 | markets.businessinsider.comEstablishment Labs earnings preview: what Wall Street is expectingJuly 31, 2024 | finance.yahoo.comBlackbird Labs rolls out blockchain payment tool for restaurantsJuly 26, 2024 | news.yahoo.comVa. education board adopts new school accreditation regulationsSee More Headlines Receive ESTA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Establishment Labs and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/06/2024Today9/12/2024Next Earnings (Estimated)11/05/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical appliances & supplies Sub-IndustryMedical Equipment Current SymbolNASDAQ:ESTA CUSIPN/A CIK1688757 Webwww.establishmentlabs.com Phone(062) 434-2400FaxN/AEmployees960Year FoundedN/APrice Target and Rating Average Stock Price Target$56.60 High Stock Price Target$70.00 Low Stock Price Target$45.00 Potential Upside/Downside+39.1%Consensus RatingModerate Buy Rating Score (0-4)2.80 Research Coverage5 Analysts Profitability EPS (Most Recent Fiscal Year)($3.14) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-78,500,000.00 Net Margins-54.97% Pretax Margin-55.61% Return on Equity-220.67% Return on Assets-29.55% Debt Debt-to-Equity Ratio4.30 Current Ratio4.44 Quick Ratio2.91 Sales & Book Value Annual Sales$151.35 million Price / Sales7.40 Cash FlowN/A Price / Cash FlowN/A Book Value$0.71 per share Price / Book57.31Miscellaneous Outstanding Shares27,515,000Free Float24,367,000Market Cap$1.12 billion OptionableOptionable Beta1.20 Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report Key ExecutivesMr. Juan Jose Chacon Quiros (Age 52)Founder, CEO & Executive Director Comp: $913.37kMr. Rajbir Singh Denhoy (Age 54)Chief Financial Officer Comp: $570.29kMr. S. Ross Mansbach (Age 57)General Counsel & Chief Compliance Officer Comp: $379.53kMr. Roberto de Mezerville (Age 43)Chief Technology Officer Mr. Salvador Santos Dada (Age 42)Head of Special Projects Comp: $468.62kMs. Rosalyn Cole d'IncelliSVP of Global Clinical, Medical & US Regulatory AffairsMs. Elizabeth Panzica NewmanVP & Head of U.S Business UnitMr. Ivan BilicSenior Vice President of Commercial Operations - OUSMs. Neeta TopraniCorporate SecretaryMore ExecutivesKey CompetitorsEargoNASDAQ:EARInogenNASDAQ:INGNInvacareNYSE:IVCWright Medical GroupNASDAQ:WMGIPROCEPT BioRoboticsNASDAQ:PRCTView All CompetitorsInsiders & InstitutionsNantahala Capital Management LLCSold 1,712 shares on 8/20/2024Ownership: 9.133%Point72 Asset Management L.P.Sold 554,877 shares on 8/19/2024Ownership: 0.058%SkyView Investment Advisors LLCBought 9,195 shares on 8/16/2024Ownership: 0.033%Affinity Asset Advisors LLCBought 8,818 shares on 8/15/2024Ownership: 0.812%Lighthouse Investment Partners LLCBought 28,038 shares on 8/15/2024Ownership: 0.155%View All Insider TransactionsView All Institutional Transactions ESTA Stock Analysis - Frequently Asked Questions How have ESTA shares performed this year? Establishment Labs' stock was trading at $25.89 on January 1st, 2024. Since then, ESTA shares have increased by 57.2% and is now trading at $40.69. View the best growth stocks for 2024 here. How were Establishment Labs' earnings last quarter? Establishment Labs Holdings Inc. (NASDAQ:ESTA) announced its quarterly earnings data on Tuesday, August, 6th. The company reported ($0.62) earnings per share for the quarter, missing the consensus estimate of ($0.51) by $0.11. Establishment Labs's revenue was down 9.2% compared to the same quarter last year. When did Establishment Labs IPO? Establishment Labs (ESTA) raised $50 million in an initial public offering on Thursday, July 19th 2018. The company issued 3,100,000 shares at a price of $15.00-$17.00 per share. Jefferies and Cowen acted as the underwriters for the IPO and BTIG was co-manager. Who are Establishment Labs' major shareholders? Establishment Labs' top institutional investors include Nantahala Capital Management LLC (9.13%), Rice Hall James & Associates LLC (2.60%), William Blair Investment Management LLC (1.75%) and Sofinnova Investments Inc. (1.56%). Insiders that own company stock include Jw Asset Management, Llc, Nicholas Sheridan Lewin, Quiros Juan Jose Chacon, Raj Denhoy, Leslie Gillin and Edward J Schutter. View institutional ownership trends. How do I buy shares of Establishment Labs? Shares of ESTA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Establishment Labs own? Based on aggregate information from My MarketBeat watchlists, some other companies that Establishment Labs investors own include AbbVie (ABBV), Enterprise Products Partners (EPD), Sientra (SIEN), Allergan (AGN), BCE (BCE), Canadian Imperial Bank of Commerce (CM) and This page (NASDAQ:ESTA) was last updated on 9/12/2024 by MarketBeat.com Staff From Our Partners⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredInvest before this deal closes on 9/18This company can create aviation fuels from waste, they qualify to help airlines meet net-zero carbon pledges ...Deal Maker | SponsoredRecently listed NASDAQ firm is well positioned for growth with game-changing AI platform for e-commerce.With an innovative AI platform, one tiny but growing NASDAQ firm is ushering in a new e-commerce era and is tr...Smallcaps Daily | SponsoredYour Ticket to the Future $75B Air Mobility Market Boom?Looking for the next big investment opportunity? This company could be your chance to catch the electric aviat...Market JAR | Sponsored“Why I don’t care if the Fed cuts rates” - SYKES In on Friday out by Monday Over the past decade I’ve made millions of dollars with a strategy I call Weeken...Timothy Sykes | SponsoredPlace this $0.99 trade BEFORE the electionEarlier this year, Millionaire Trader Nate Bear of Monument Traders Alliance went live in front of thousands o...Monument Traders Alliance | SponsoredJeff Bezos Just Humiliated Elon MuskThe Next Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the next...InvestorPlace | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Establishment Labs Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Establishment Labs With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
